Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-07T12:44:47.302Z Has data issue: false hasContentIssue false

The evolution of metabolic profiling in parasitology

Published online by Cambridge University Press:  05 May 2010

E. HOLMES*
Affiliation:
Biomolecular Medicine, Department of Surgery and Cancer, Imperial College, London SW7 2AZ
*
Corresponding author: Tel.: +44(0)207 594 3220; Fax: +44(0)207 594 3226; E-mail: elaine.holmes@imperial.ac.uk
Rights & Permissions [Opens in a new window]

Summary

The uses of metabolic profiling technologies such as mass spectrometry and nuclear magnetic resonance spectroscopy in parasitology have been multi-faceted. Traditional uses of spectroscopic platforms focused on determining the chemical composition of drugs or natural products used for treatment of parasitic infection. A natural progression of the use of these tools led to the generation of chemical profiles of the parasite in in vitro systems, monitoring the response of the parasite to chemotherapeutics, profiling metabolic consequences in the host organism and to deriving host-parasite interactions. With the dawn of the post-genomic era the paradigm in many research areas shifted towards Systems Biology and the integration of biomolecular interactions at the level of the gene, protein and metabolite. Although these technologies have yet to deliver their full potential, metabolic profiling has a key role to play in defining diagnostic or even prognostic metabolic signatures of parasitic infection and in deciphering the molecular mechanisms underpinning the development of parasite-induced pathologies. The strengths and weaknesses of the various spectroscopic technologies and analytical strategies are summarized here with respect to achieving these goals.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2010
Figure 0

Fig. 1. Schematic showing examples of common spectral inputs and model outputs used in metabolic profiling studies. Different types of spectral data (e.g. NMR, UPLC-MS, CE) are modelled using a range of multivariate techniques, which each have advantages and limitations in terms of characterization of pathology, visualisation of samples and ease of extraction of discriminatory metabolites or potential biomarkers of a particular infection. Self organising mapping is a type of artificial neural network that allows organisation of the data according to a property of interest in a 2-dimensional space. Hierarchical cluster analysis is typically an unsupervised approach to generating a hierarchy of clusters of objects based on a calculated similarity matrix, the shorter the branch length, the more similar the objects are. PLS-DA (Partial Least Squares Discriminant Analysis) uses classification information to maximise the differential between two or more classes of objects and is typically displayed as scores plots (showing the similarity between objects – the nearer two coordinates are, the more similar the spectra) and coefficient plots (indicating the contribution of the variables, or metabolites in differentiating the classes).